About Us | Respiratory Conference | Pulmonology Conferences

The defining element of terrestrial life is respiration, the air that we breathe. Most if not all self-aware respiratory organisms take this for granted, but the last several years have seen this paradigm turned on its head, as a respiratory pandemic has consumed the global human population, leaving in its wake a trail of loss and devastation. This respiratory conference will be the world’s foremost pulmonology meeting for all eminent professionals dealing with respiratory and respiratory research science to come together and enrich this event with their research findings and experiences. This Respiratory Conference offers over 10 scientific tracks from different research areas in the field of respiratory and respiratory research science in the form of keynote presentations, plenary sessions, oral sessions, panel discussions, poster presentations, and young researchers’ forums. The Respiratory Conference is going to be held in Zurich, Switzerland, during Jun 15-16, 2023. This most awaited Respiratory Conference 2023 will address the succeeding research and development in the field of allergic rhinitis, asthma, cardiopulmonary disorders, acute respiratory distress syndrome (ARDS), and lung cancer and this will provide a major opportunity for collaboration and interaction among all pulmonologists, research scholars and health care personnel. Respiratory Conference will become the leading platform for bringing together all experts and beginners for a friendly and effective research-oriented discussion.

The goal of Longdom Conferences is to bring together scientists at every level from diverse disciplines to understand and discuss throughout the programmed sessions and comfortable gatherings. All these opportunities will support the professional growth of younger scientists that will promote future collaborations and enhance participation and contribution to their exciting research work.

Why join LONGDOM Conferences?

Understand the current state of research | Meet international colleagues and experts | Visit the exhibition of leading-edge technology | Engage with editors of the top journals in your field | Global networking and certification | Brand Launching and many more to explore

Who will be the participants?

Scientific Tracks

Track 1: Pathogenesis of COPD

Chronic Obstructive Pulmonary Diseases (COPD) cause blockages within the air tubes that carry air in and out of the lungs. Air tubes become narrower. Due to this lung feel terribly full, the chest feels tight, and feel wants to breathe. Principally chronic cough with or while not secretion we tend to found. The highest reason for COPD is tobacco smoking. Long-run exposure to chemical irritants may result in COPD. Some folks with COPD have a deficiency in an exceedingly macromolecule known as alpha-1-antitrypsin. This deficiency causes the lungs to deteriorate and can also have an effect on the liver. There are also alternative associated genetic factors at play in addition.

Track 2: Pulmonary Infections & Treatment

One of the foremost common kinds of pulmonary infections is named respiratory illness. This affects the smaller air sacs of the lungs, is most frequently caused by contagious microorganisms, however, it may also be caused by a virulent disease. An individual becomes infected by inhaling the microorganism or virus when a close-by infected person sneezes or coughs. We want to remain at a hospital throughout recovery. Throughout the keep, it's going to receive antibiotics, endovenous fluids, and metabolic process medical aid.

Track 3: Asthma Immunology & Medication

Asthma may be a common malady that affects three hundred million folks worldwide. Given the massive variety of eosinophil within the airways of individuals with gentle respiratory care, and verified by information from murine models. the proper medications for you rely upon variety of things like age, symptoms, triggers and what works best to stay asthma in restraint, Preventive, long management medications cut back the inflammation in airways that results in symptoms. Quick-relief inhalers quickly open swollen airways that are limiting respiration. In some cases, allergic reaction medications are necessary.

Track 4: Lungs Disease & Their Cause

The lungs area unit is a part of fancy equipment, increasing and quiet thousands of times on a daily basis to the user in element and expel CO2. Respiratory organ illness may result from issues in any part of this technique. The trachea (windpipe) branches into tubes referred to as bronchi that successively branch to become more and more small tubes throughout the lungs. Bacteria, viruses, and fungi are unit renowned to cause opening pneumonia. Regular exposure to inhaled irritants at work or throughout hobbies may cause some open respiratory disease.

Track 5: Chronic Respiratory Diseases

Chronic respiratory diseases (CRDs) are diseases of the airways and different structures of the respiratory organ. Additionally to tobacco smoke, different risk factors embrace pollution, activity chemicals and dusts, and frequent lower metabolic process infections throughout childhood. CRDs don't seem to be curable, however, varied varieties of treatment that facilitate dilate major air passages and improve shortness of breath will facilitate management symptoms and increase the standard of life for individuals with the malady.

Track 6: Respiratory Pharmacology & Care

There are so many therapies includes under respiratory disease like, inhaled glucocorticoids: Bind to glucocorticoid receptors on cells recruiting fast array of transcription factors that act as feedback mechanism to regulate inflammation. Providing home care to clients with respiratory disease is to improve survival, decrease morbidity, encourage independence and self-management, and improve quality of life. For clients with terminal respiratory disease, the focus of care is on pain management and psychological comfort, making dying as comfortable as possible.

Track 7: Acute Respiratory Distress Syndrome

ARDS occurs when fluid fills up the air sacs in lungs. Too much fluid in lungs can lower the amount of oxygen or increase the amount of carbon dioxide in the bloodstream. ARDS can prevent the organs from getting the oxygen they need to function, and it can eventually cause organ failure. The common symptoms of ARDS are larboard and rapid breathing, muscles fatigue and general weakness, low blood pressure, fever, and headache.

Track 8: Potential Indoor Air Treatments to Prevent Disease Transmission

Arguably, the defining element of terrestrial life is respiration, the air that we breathe. Most if not all self-aware respiratory organisms take this for granted, but the last several years have seen this paradigm turned on its head, as a respiratory pandemic has consumed the global human population, leaving in its wake a trail of death and devastation. This conference comes at a critical time in the pandemic, providing an opportunity to take stock of where we have come from and where we are, to compare notes, to divulge what we have learned thus far, what works and what doesn't work, and what we can propose going forward to secure effective medical care, the health of the air we breathe, indeed our very survival. In this spirit, I welcome you, my colleagues, and allies in this war which remains ongoing. Failure is not an option.

Track 9: Pulmonary vascular disease

Pulmonary vascular disease (PVD) is a broad term including any condition that affects the blood vessels within the lungs. These vessels take blood that is depleted of oxygen to the lungs from the right side of the heart. Deoxygenated blood travels through the pulmonary arteries where oxygen is taken up. The pulmonary veins leave the lungs and take blood rich in oxygen to the left side of the heart where oxygenated blood is distributed throughout the body. This process continually refills the blood with oxygen and lets carbon dioxide be exhaled. A pulmonary vascular disorder can lead to cardiovascular problems as well as damage the quality of the patient’s life.

Track 10: Cardiopulmonary Disorders

The term cardiopulmonary disease describes a wide range of conditions that affect the heart and lungs and we invite all members to join the Cardiopulmonary Disorders Conference to get updated in this field. These organs are closely connected and a problem in one can spill over to the other. For example, when the heart is not able to pump blood efficiently | normal oxygen movement in the lungs is reduced | causing shortness of breath. On the other hand | a problem with the lungs can cause the heart to have to work harder to get oxygen from the lungs into the blood.

Common types of this disease include:

Chronic bronchitis
Chronic obstructive pulmonary disease (COPD)
Congestive heart failure
Emphysema

Related Societies:

Market Analysis Report for Respiratory Conference 2023

Covid19 impact on the global anesthesia & respiratory market

Due to COVID19, the global anesthesia, respiratory and sleep therapy devices market saw an increase of 14.4% in 2020 from a valuation of nearly $9.6 billion in 2019. The latest analysis shows the global experiencing a moderate decline in 2021, after a spike in market demand in 2020.

The COVID-19 pandemic had a massive impact on the entire market. While it adversely affected the anesthesia market, respiratory market segments experienced unprecedented growth due to a continent-wide state of emergency and a surge in demand for these products. However, the effects are only temporary and are expected to correct themselves in the recovery years due to over-purchasing and a transition back to pre-pandemic conditions.

European ventilator market insights

The overall U.S. ventilator market grew significantly in 2020, due to the increased number of patients requiring respiratory support from COVID-19 complications. The acute care and emergency transport segments saw the most pronounced growth, while home care and neonatal ventilators took small steps backward in 2020. Due to the abnormally high sales numbers and the influx of ventilators into the market, the market is expected to decrease significantly in 2021 and again in 2022.

The U.S. ventilator market can be segmented by the device’s level of sophistication and location of use. The six categories are acute care ventilators, sub-acute care ventilators, home care ventilators, neonatal ventilators, non-invasive ventilators, and emergency transport ventilators. These products are tailored to meet the needs of different age groups or individuals with specific physiological limitations.

Past Conferences/ Webinars Reports

Longdom Conferences have taken a major role in this pandemic time in organizing the most beneficial and interactive webinars. These are time-saving, economic, and interactive programs that include case-based presentations, online assessments, and live discussions with speakers and global researchers. Eminent speakers of the Longdom webinars, who are leading in providing useful tips for daily clinical practice and professional growth from basic to advanced research subjects.

Respiratory Disease 2022 Report

3rd International Conference on Respiratory Disease and Care, hosted by the Longdom Conference was held on December 12-13, 2022 on the theme “Current Advances in Respiratory Care"